FDAFDA · Food and drugs·Recall number D-324-2013
Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, UPC 3 61958 01011 5; NDC 61958-0101-1.
Published May 22, 2013 · Recall initiated: January 31, 2013
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).
What to do
Voluntary: Firm initiated · E-Mail
Recall details
- Manufacturer
- Gilead Sciences, Inc.
- Distributor
- Nationwide in USA, Canada, and UK (Gilead facility in Cork Ireland). Cork facility distributed to Germany/Austria, Italy and Spain.
- Lot
- Lot #: B120217A, Exp 05/15 - US Distribution
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.